Bruker Corp (BRKR)
66.03
-0.51
(-0.77%)
USD |
NASDAQ |
Jun 21, 16:00
66.01
-0.02
(-0.03%)
Pre-Market: 20:00
Bruker Research and Development Expense (TTM): 307.60M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 307.60M |
| December 31, 2023 | 294.80M |
| September 30, 2023 | 274.80M |
| June 30, 2023 | 259.70M |
| March 31, 2023 | 248.30M |
| December 31, 2022 | 235.90M |
| September 30, 2022 | 230.50M |
| June 30, 2022 | 226.40M |
| March 31, 2022 | 222.60M |
| December 31, 2021 | 220.80M |
| September 30, 2021 | 219.80M |
| June 30, 2021 | 216.00M |
| March 31, 2021 | 204.30M |
| December 31, 2020 | 198.00M |
| September 30, 2020 | 187.60M |
| June 30, 2020 | 185.40M |
| March 31, 2020 | 189.80M |
| December 31, 2019 | 187.70M |
| September 30, 2019 | 185.80M |
| June 30, 2019 | 181.50M |
| March 31, 2019 | 176.60M |
| December 31, 2018 | 173.40M |
| September 30, 2018 | 171.70M |
| June 30, 2018 | 170.50M |
| March 31, 2018 | 167.20M |
| Date | Value |
|---|---|
| December 31, 2017 | 161.60M |
| September 30, 2017 | 155.60M |
| June 30, 2017 | 152.90M |
| March 31, 2017 | 149.40M |
| December 31, 2016 | 147.90M |
| September 30, 2016 | 147.50M |
| June 30, 2016 | 143.90M |
| March 31, 2016 | 144.60M |
| December 31, 2015 | 145.70M |
| September 30, 2015 | 150.60M |
| June 30, 2015 | 158.40M |
| March 31, 2015 | 165.40M |
| December 31, 2014 | 174.20M |
| September 30, 2014 | 181.70M |
| June 30, 2014 | 185.10M |
| March 31, 2014 | 187.10M |
| December 31, 2013 | 190.50M |
| September 30, 2013 | 191.70M |
| June 30, 2013 | 191.10M |
| March 31, 2013 | 196.50M |
| December 31, 2012 | 195.30M |
| September 30, 2012 | 189.70M |
| June 30, 2012 | 188.30M |
| March 31, 2012 | 180.70M |
| December 31, 2011 | 177.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
181.50M
Minimum
Jun 2019
307.60M
Maximum
Mar 2024
223.86M
Average
220.30M
Median
Research and Development Expense (TTM) Benchmarks
| NS Wind Down Co Inc | 70.53M |
| Azenta Inc | 35.10M |
| Harvard Bioscience Inc | 11.75M |
| Bionano Genomics Inc | 49.88M |
| Akoya Biosciences Inc | 21.67M |